Hims & Hers Health Inc. 美股盘后暴涨近40%,消息称诺和诺德计划在Hims & Hers Health Inc.的平台上销售减肥药,从而终结两家公司之间一场复杂的商业纠纷,该纠纷上月曾升级为法律诉讼。
知情人士表示,诺和诺德与Hims最早可能于下周一宣布建立新的合作关系。两家公司去年曾达成类似协议,但在Hims拒绝停止营销和销售仿制版本药物后,诺和诺德单方面终止了协议。
Hims & Hers Health Inc. 美股盘后暴涨近40%,消息称诺和诺德计划在Hims & Hers Health Inc.的平台上销售减肥药,从而终结两家公司之间一场复杂的商业纠纷,该纠纷上月曾升级为法律诉讼。
知情人士表示,诺和诺德与Hims最早可能于下周一宣布建立新的合作关系。两家公司去年曾达成类似协议,但在Hims拒绝停止营销和销售仿制版本药物后,诺和诺德单方面终止了协议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.